NPSR1 and Parkinson disease: Considering the focus of this review on the NPS system as an innovative therapeutic target to treat Parkinson disease (PD), it is essential to emphasize that NPSR mRNA is expressed in dopaminergic areas, such as the substantia nigra pars compacta and ventral tegmental area [6,7].